FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1957230393> ?p ?o ?g. }

• W1957230393 endingPage "74" @default.
• W1957230393 startingPage "568" @default.
• W1957230393 abstract "The hypothesis that adjuvant treatment designed to produce testicular atrophy would preserve fertility in males receiving cancer chemotherapy was examined in the rat. Testicular atrophy was induced by a depot formulation of Zoladex [D-Ser(Bu(t))6-Aza-Gly10-GnRH], a gonadotropin-releasing hormone (GnRH) analogue. The experiments were conducted in albino Wistar as well as in the piebald variegated rat. Rats received the depot Zoladex formulation 2 weeks before and immediately prior to being treated with four weekly doses of procarbazine (200 mg/kg). Testicular function was evaluated 50 and 90 days after the last procarbazine dose. Procarbazine induced testicular atrophy concomitant with marked germinal cell aplasia in both strains of rat. In the Wistar rat adjuvant treatment with Zoladex caused slight but not significant alleviation of the testicular toxicity of procarbazine. The testicular toxicity of procarbazine was more extensive in the piebald variegated rat, and 50 days after the last procarbazine treatment the testes were small, sperm were absent, and the stem cell index was close to zero. Serum luteinizing hormone (LH) concentrations were raised and testicular LH receptor binding was low in the presence of normal serum and testicular testosterone concentrations, indicating compensated Leydig cell failure. Testicular weight and sperm content, as well as LH receptor binding, were still decreased in rats which received both Zoladex and procarbazine, suggesting that the analogue offered no protection. However, the stem cell index of the seminiferous tubules in the procarbazine-Zoladex-treated rats was not significantly different from vehicle-treated rats, which suggested that recovery from the effects of procarbazine was in progress. Ninety days after the end of procarbazine treatment alone the testes of rats were still atrophied and there was little evidence of active spermatogenesis. Leydig cell failure appeared to have progressed as, in addition to the low testicular LH receptor content and raised serum LH concentration, the prostate and seminal vehicle weights were decreased. The combination of Zoladex treatment with procarbazine was successful in preserving testicular function in the piebald variegated rats as virtually all the functional and morphological parameters of both the seminiferous tubule and the Leydig cell were not significantly different from those of vehicle-treated rats. This study demonstrates for the first time that effective gonadal protection from the toxic effects of procarbazine chemotherapy can be achieved by administration of the depot formulation of the gonadotropin-releasing hormone analogue Zoladex. The results show clearly that complete suppression of spermatogenesis is not a prerequisite for the successful outcome of treatments designed to protect the gonad from cytotoxic chemotherapy." @default.
• W1957230393 created "2016-06-24" @default.
• W1957230393 creator A5009497247 @default.
• W1957230393 creator A5023022434 @default.
• W1957230393 creator A5031050575 @default.
• W1957230393 creator A5054207965 @default.
• W1957230393 creator A5057793277 @default.
• W1957230393 date "1990-02-01" @default.
• W1957230393 modified "2023-09-23" @default.
• W1957230393 title "Protection of spermatogenesis in rats from the cytotoxic procarbazine by the depot formulation of Zoladex, a gonadotropin-releasing hormone agonist." @default.
• W1957230393 cites W1480260324 @default.
• W1957230393 cites W1488146021 @default.
• W1957230393 cites W162630147 @default.
• W1957230393 cites W1765236658 @default.
• W1957230393 cites W183917128 @default.
• W1957230393 cites W1976039836 @default.
• W1957230393 cites W1989090188 @default.
• W1957230393 cites W1996294678 @default.
• W1957230393 cites W1999340517 @default.
• W1957230393 cites W2004660228 @default.
• W1957230393 cites W2006969256 @default.
• W1957230393 cites W2034211718 @default.
• W1957230393 cites W2046085320 @default.
• W1957230393 cites W2050410950 @default.
• W1957230393 cites W2072487355 @default.
• W1957230393 cites W2074185602 @default.
• W1957230393 cites W2086517449 @default.
• W1957230393 cites W2090697085 @default.
• W1957230393 cites W2134782634 @default.
• W1957230393 cites W2240906944 @default.
• W1957230393 cites W2413100373 @default.
• W1957230393 cites W1992820759 @default.
• W1957230393 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/2137024" @default.
• W1957230393 hasPublicationYear "1990" @default.
• W1957230393 type Work @default.
• W1957230393 sameAs 1957230393 @default.
• W1957230393 citedByCount "28" @default.
• W1957230393 countsByYear W19572303932012 @default.
• W1957230393 countsByYear W19572303932014 @default.
• W1957230393 countsByYear W19572303932018 @default.
• W1957230393 crossrefType "journal-article" @default.
• W1957230393 hasAuthorship W1957230393A5009497247 @default.
• W1957230393 hasAuthorship W1957230393A5023022434 @default.
• W1957230393 hasAuthorship W1957230393A5031050575 @default.
• W1957230393 hasAuthorship W1957230393A5054207965 @default.
• W1957230393 hasAuthorship W1957230393A5057793277 @default.
• W1957230393 hasConcept C123765429 @default.
• W1957230393 hasConcept C126322002 @default.
• W1957230393 hasConcept C134018914 @default.
• W1957230393 hasConcept C185592680 @default.
• W1957230393 hasConcept C2776694085 @default.
• W1957230393 hasConcept C2776755627 @default.
• W1957230393 hasConcept C2777892665 @default.
• W1957230393 hasConcept C2778575703 @default.
• W1957230393 hasConcept C2779112685 @default.
• W1957230393 hasConcept C2779279991 @default.
• W1957230393 hasConcept C2779429289 @default.
• W1957230393 hasConcept C71315377 @default.
• W1957230393 hasConcept C71924100 @default.
• W1957230393 hasConcept C86803240 @default.
• W1957230393 hasConceptScore W1957230393C123765429 @default.
• W1957230393 hasConceptScore W1957230393C126322002 @default.
• W1957230393 hasConceptScore W1957230393C134018914 @default.
• W1957230393 hasConceptScore W1957230393C185592680 @default.
• W1957230393 hasConceptScore W1957230393C2776694085 @default.
• W1957230393 hasConceptScore W1957230393C2776755627 @default.
• W1957230393 hasConceptScore W1957230393C2777892665 @default.
• W1957230393 hasConceptScore W1957230393C2778575703 @default.
• W1957230393 hasConceptScore W1957230393C2779112685 @default.
• W1957230393 hasConceptScore W1957230393C2779279991 @default.
• W1957230393 hasConceptScore W1957230393C2779429289 @default.
• W1957230393 hasConceptScore W1957230393C71315377 @default.
• W1957230393 hasConceptScore W1957230393C71924100 @default.
• W1957230393 hasConceptScore W1957230393C86803240 @default.
• W1957230393 hasIssue "3" @default.
• W1957230393 hasLocation W19572303931 @default.
• W1957230393 hasOpenAccess W1957230393 @default.
• W1957230393 hasPrimaryLocation W19572303931 @default.
• W1957230393 hasRelatedWork W1976688049 @default.
• W1957230393 hasRelatedWork W1984559885 @default.
• W1957230393 hasRelatedWork W1992331803 @default.
• W1957230393 hasRelatedWork W1999611386 @default.
• W1957230393 hasRelatedWork W2012502375 @default.
• W1957230393 hasRelatedWork W2047880909 @default.
• W1957230393 hasRelatedWork W2153860757 @default.
• W1957230393 hasRelatedWork W2169932845 @default.
• W1957230393 hasRelatedWork W2313856518 @default.
• W1957230393 hasRelatedWork W2411910748 @default.
• W1957230393 hasVolume "50" @default.
• W1957230393 isParatext "false" @default.
• W1957230393 isRetracted "false" @default.
• W1957230393 magId "1957230393" @default.
• W1957230393 workType "article" @default.